Positive results from the Tezspire phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps: Cambridge, UK Tuesday, March 4, 2025, ...

Amgen (AMGN) and AstraZeneca (AZN) announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE ...

"Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP" was originally created and published by ...

Lexington-based nonprofit hosts an array of outings for people with disabilities ...

The partners are building toward a regulatory submission for Tezspire in chronic rhinosinusitis with nasal polyps in the ...

Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for ...

I find it really special and feel very honoured when people share their own original music with me and then we start working ...

Ord Minnett analyst Milo Ferris maintained a Buy rating on Waypoint REIT Ltd. (WPR – Research Report) today and set a price target of A$2.72.

Waypoint REIT is an internally managed Australian real estate investment trust. It owns a portfolio of about 400 service station properties, mainly leased to ASX-listed Viva Energy. About 80% of ...

Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) significantly reduced nasal polyp severity, the need for subsequent surgery ...

THE TRICK FOR GOING DOWNHILL IS JUST KEEP YOUR WEIGHT FORWARD. ALL PART OF AN OUTING PLANNED BY WAYPOINT ADVENTURE. SO THEY’RE LEARNING TECHNIQUES ABOUT HOW TO HOLD YOURSELF IN POSITION ON THE ...